ID   S58-SF
AC   CVCL_1Y18
SY   SUIT-58-Serum Free
DR   FCS-free; 166-2-308-1-3-3
DR   Wikidata; Q54951958
RX   PubMed=26141632;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 35.7 hours (PubMed=26141632).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Y17 ! SUIT-58
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 12
//
RX   PubMed=26141632; DOI=10.1007/s13577-015-0122-6;
RA   Takahashi N., Aoyama F., Ohuchida J., Sameshima N., Asada Y.,
RA   Sawaguchi A.;
RT   "Establishment and characterization of SUIT-58 pancreas cancer cell
RT   line and its subline S58-SF adapted to serum-free condition derived
RT   from metastatic liver tumor.";
RL   Hum. Cell 28:190-198(2015).
//